European Union Chamber Of Commerce In China Calls For An End To Protectionism And Discrimination
• By PharmAsia News
BEIJING - While acknowledging China's economic expansion despite the global financial crisis, the leaders of the European Union Chamber of Commerce in China are calling on Beijing to create a more level playing field for foreign-funded firms across the country
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
Pharma company financial guidance emerged largely unscathed from a first quarter punctured by a weakening US dollar and threats of import tariffs on drugs. With other pressures either already evident or on the horizon, guidance revisions may be unavoidable.
Aside from several sizable global out-licensing deals, South Korean bioventures saw a cancellation of other alliances, updated their pipelines with losses and gains and reported clinical trial progress in the second quarter, while domestic IPO sentiment also improved.
New US approval in heart failure with preserved or mildly reduced ejection fraction should add to Kerendia’s earning power on top of chronic kidney disease indication.